SEB Asset Management’s AstraZeneca AZN Stock Holding History

SEB Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08B	Sell	5,736,648 -217,769	-4%	-$41M	4.06%	3
2026 Q1	$1.16B	Buy	+5,954,417	New	+$1.15B	4.95%	3

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return

SEB Asset Management's AZN Position: Q2 2026 in Review

SEB Asset Management reduced its AstraZeneca (AZN) stake by 3.7% in Q2 2026, selling an estimated $41M and leaving 5,736,648 shares worth $1.08B. The position accounts for 4.06% of the portfolio, ranked #3.

SEB Asset Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.16B in Q1 2026. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

SEB Asset Management held 5,736,648 shares of AstraZeneca worth $1.08B as of Q2 2026.
SEB Asset Management sold 217,769 AstraZeneca shares in Q2 2026, an estimated $41M.
AstraZeneca made up 4.06% of SEB Asset Management's portfolio in Q2 2026, its #3 holding.
SEB Asset Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
SEB Asset Management's AstraZeneca position peaked at $1.16B in Q1 2026.
1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.